Results 141 to 150 of about 56,774 (264)
Brain and Behavior, Volume 16, Issue 2, February 2026.The overall body of evidence does not provide strong support for a preventive role of the Mediterranean diet in multiple sclerosis (components of the graph are retrieved from Servier Medical Art by Servier, licensed under a Creative Commons Attribution 3.0, Unported (CC BY 3.0)).
Fatemeh Shakouri +5 more
wiley +1 more source
Bithalamic Inflammation in Relapsing-Remitting Multiple Sclerosis [PDF]
The Neurohospitalist, 2017 Andrew R, Romeo, Maulik, Shah
openaire +2 more sources
Brain and Behavior, Volume 16, Issue 2, February 2026.This study aimed to describe and compare information on diagnoses of MS and related disorders as well as treatments with disease‐modifying therapies (DMTs) available in three national registries, highlighting the key differences relevant to MS research.
Hanna Joensen +3 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 2, February 2026.Comorbidity was present in approximately half of the patients with relapsing‐remitting multiple sclerosis in this Finnish cross‐sectional cohort. Comorbidities, especially psychiatric diseases, were associated with lower persistence on injectable disease‐modifying treatments.
Henrik Ahvenjärvi +4 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 2, February 2026.The gut microbiome in multiple sclerosis (MS) shows consistent depletion of short‐chain fatty acid (SCFA)‐producing bacteria, expansion of pro‐inflammatory species, and reduced levels of butyrate, propionate, and indole metabolites. These alterations increase intestinal permeability, disrupt immune balance, and contribute to blood–brain barrier ...
Husna Irfan Thalib +7 more
wiley +1 more source
Clinical &Translational Immunology, Volume 15, Issue 2, 2026.Antibody response to vaccination in people with multiple sclerosis receiving B‐cell depletion therapy is associated with B‐cell frequency but not time since B‐cell depletion. Immunoregulatory CD56bright NK cells may negatively impact antibody responses in this group.
Griffith B Perkins +21 more
wiley +1 more source
مجله دانشکده پزشکی اصفهان, 2017 Background: The aim of this study was to determine the efficacy of monthly cyclophosphamide and daily fingolimod in treatment of patients with multiple sclerosis (MS) and to compare these two treatment strategies.
Vahid Shaygannezhad, Hassan Amini
doaj
European Journal of Immunology, Volume 56, Issue 2, February 2026.Mechanism of action of the intestinal microbiota on CNS autoimmune diseases. Environmental factors shape gut microbiota composition; dysbiosis alters microbial metabolites and antigenic signals. These modulate innate and adaptive immunity, affect barrier integrity, and influence CNS‐resident cells such as microglia and astrocytes, contributing to ...
Matteo Ceccon, Francesca Ronchi
wiley +1 more source
Suppressive CD8+ T‐Cells Are Key Cellular Mediators of Extracorporeal Photopheresis
Journal of Clinical Apheresis, Volume 41, Issue 1, February 2026.ABSTRACT Extracorporeal photopheresis (ECP) is a widely utilized immunomodulatory procedure with an incompletely defined mechanism. In graft‐versus‐host disease (GvHD) and transplant rejection, ECP is thought to induce immune tolerance by increasing regulatory CD4+ T‐cells, whereas in cutaneous T cell lymphoa it may enhance dendritic cell–mediated ...
Kai J. Rogers +7 more
wiley +1 more source
MedComm, Volume 7, Issue 2, February 2026.Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo +11 more
wiley +1 more source